Home » Newsletters » BioWorld

BioWorld

Aug. 10, 1993

View Archived Issues

REPLIGEN'S AM285 INHIBITS TUMORS

ZYNAXIS SEEKS MARKETING APPROVAL

SKB, IGI TO JOINTLY TEST VACCINE

REGENERON REPORTS PHASE II RESULTS

NOVEL GENE DEFECT FOUND FOR DMD

CEPHALON RAISES $3 MILLION

FDA PANEL RECOMMENDS PULMOZYME

DYNAGEN COMPLETES REGULATION S FINANCING

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 16, 2026.
AAIC 2026: Age of amyloid is being joined by time of tau
BioWorld
The Alzheimer’s Association International Conference (AAIC) is the world’s biggest dementia conference. And at the AAIC 2026 meeting, there is big buzz around...
Celia trial: data strong, analysts skeptical
BioWorld
Tuesday brought what was arguably the most anticipated presentation of the 2026 Alzheimer’s Association International Conference when Catherine Mummery, head of...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 14, 2026
Voyager’s gene therapy reduces tau levels in AD models
BioWorld Science
At the Alzheimer’s Association International Conference, researchers from Voyager Therapeutics Inc. presented preclinical efficacy data for VY-1706, a blood-brain...